Abstract

Clinical Characteristics and Follow-up Post-Surgery of Women with Bia-ALCL Operated at a Single Institution

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma
Gunjan L Shah ... M Lia Palomba
Blood | VOL. 134
Gunjan L Shah, et. al.Gunjan L Shah ... M Lia Palomba
13 Nov 2019
Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Multicenter Retrospective Analysis
Victor M Orellana-Noia ... Tatyana A Feldman
Blood | VOL. 134
Victor M Orellana-Noia, et. al.Victor M Orellana-Noia ... Tatyana A Feldman
13 Nov 2019
CD5-Positive Marginal Zone Lymphoma: Clinical Characteristics of the MSKCC Cohort, and Comparison with the CD5-Negative Population
Philip Caron ... Anita Kumar
Blood | VOL. 136
Philip Caron, et. al.Philip Caron ... Anita Kumar
05 Nov 2020
Incidence of Delayed Seromas and Related Risk of Bia-ALCL in a Cohort of 3521 Breast Cancer Women with Textured Implants Prospectively Followed Long Term
Venkatraman Seshan ... Steven M Horwitz
Blood | VOL. 134
Venkatraman Seshan, et. al.Venkatraman Seshan ... Steven M Horwitz
13 Nov 2019
View more papers

More From: Blood

Paper Title
Journal
Date
Author
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma.
Ola Landgren ... Sean M Devlin
Blood | VOL. -
Ola Landgren, et. al.Ola Landgren ... Sean M Devlin
20 May 2024
Increased risk of venous thromboembolism in young and middle-aged individuals with hereditary angioedema: a family study.
Linda Sundler Björkman ... Bengt Zöller
Blood | VOL. -
Linda Sundler Björkman, et. al.Linda Sundler Björkman ... Bengt Zöller
17 May 2024
Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib.
Jennifer A Woyach ... Veerendra Munugalavadla
Blood | VOL. -
Jennifer A Woyach, et. al.Jennifer A Woyach ... Veerendra Munugalavadla
16 May 2024
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Chiara Malinverni ... Carlo Visco
Blood | VOL. -
Chiara Malinverni, et. al.Chiara Malinverni ... Carlo Visco
16 May 2024
View more papers